跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial - TGA Drug Approval Details
Approvals
/
TGA
/
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
Approved
STANDARD
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8b8a0801b2a46ea3
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
8b8a0801b2a46ea3
Product Name
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
Artg Id
309381
Artg Name
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2018-09-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/92630be81a5cb8a169a2a19189250373.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8d43e8ba20da964ca4209f0be37c820b.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8b8a0801b2a46ea3
Type
Standard
Back to TGA Approvals